Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why Did Rheumatoid Arthritis Begin in 1800?

Staff  |  Issue: September 2012  |  September 5, 2012

What is RA’s connection with citrullination and anticitrullinated protein (ACPA) antibodies? The fundamental role of ACPAs and RA is now accepted, with considerable attention now to investigating their role in pathogenesis of disease (which is mostly beyond the scope of this discussion). ACPAs precede RA, are predictive of RA, and have been found in serum and synovial immune deposits in patients with early and established disease.18-26 Antibodies to human citrullinated alpha enolase and P. gingivalis enolase cross react, suggesting important linkage and/or molecular mimicry in disease pathogenesis.27 Studies of the repertoires of ACPAs in RA patients with and without periodontal disease showed distinct ACPA reactivities compatible with the possibility that uncitrullinated peptide breaks tolerance in periodontal disease with epitope spreading to citrullinated epitopes. This, in some patients, might eventuate in or contribute to RA.28

Further, patients with RA had antibodies to P. gingivalis more frequently than controls, although less frequently than patients with periodontal disease, and with correlations to RA-related autoantibody and CRP levels.29 And, in patients with RA, both patients and their relatives had antibodies to P. gingivalis, which were associated with ACPA.30 These observations are consistent with a role for P. gingivalis in RA, but do not themselves represent proof, as other explanations for these data are possible.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Finally, are there experimental studies examining these putative associations? These were interesting. In one study, mice (DR4-IE transgenic, C57BL/6, and control) were immunized with recombinant human alpha enolase and P. gingivalis enolase, citrullinated or uncitrullinated; DR4-IE subjects developed arthritis and antibodies to citrullinated and unmodified human alpha enolase and arginine-bearing control peptide. These data support a possible role for P. gingivalis enolase in RA.31 In other experiments, using a model of chronic antigen-induced arthritis, it was found that the model mimicked several features of RA and periodontal disease, with associated manifestations of both disorders.32

Whether or not importation of sugar from the Americas led to emergence of RA in Europe may never be known. But, certainly, RA and periodontal disease share common clinical, immunopathologic, serologic, and epidemiologic features. Several lines of evidence intersect at P. gingivalis and its peptidyl arginine deiminase, suggesting a role in the immunopathogenesis of RA.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Panush is professor of medicine, division of rheumatology, department of medicine, Keck School of Medicine, University of Southern California in Los Angeles.

References

  1. Panush RB, Caldwell JR, Panush RS. Corot’s ‘gout’ and a ‘gypsy girl’. JAMA. 1990;204:1136-1138.
  2. Panush RS. Rheum With A View. Why I sometimes read poetry instead of medicine—and why you should, too. The Rheumatologist, November 2011, pp 47-49.
  3. Short C. The antiquity of rheumatoid arthritis. Arthritis Rheum. 1974;17:193-205.
  4. Garrod AB. The Nature and Treatment of Gout and Rheumatic Gout. London, Walton and Maberly, 1859.
  5. Buchanan WW, Murdoch RM. That rheumatoid arthritis will disappear. J Rheum. 1979;6:324-329.
  6. Appelboom T, ed. Art, History and Antiquity of Rheumatic Diseases. Elsevier, Brussels, Erasmus Foundation, 1987.
  7. Rosenstein ED, Greenwald RA. Kushner LJ, Weissmann G. Hypothesis: The humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28:311-318.
  8. Weissmann G. Is sugar the missing link in RA? Internal Medicine News. 2006;39(16):11.
  9. Weissmann G. The pathogenesis of rheumatoid arthritis. Bull NYU Hospital for Joint Diseases. 2006;64:12-15.
  10. Rosenstein ED, Weissmann G, Greenwald RA. Porphyromonas gingivalis, periodontitis and rheumatoid arthritis. Med Hypotheses. 2009;73:457-458.
  11. Kubetin SK. Single enzyme implicated in periodontitis link to RA. Rheumatology News. May 1, 2010, p 24.
  12. Rosenstein ED, Scher JU, Bretz WA, Weissmann G. Rheumatoid arthritis and periodontitis: A possible link via “citation.” Anaerobe. 2012;18:162.
  13. Gleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res. 1998;3:387-392.
  14. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001;72:779-787.
  15. Loyola-Rodrigues JP, Martinez-Martinez RWE, Abud-Mendoza C, Patino-Marin BN, Seymour GJ. Rheumatoid arthritis and the role of oral bacteria. J Oral Microbiol. 2010; 2:5784.
  16. Routsias JG, Goules JD, Charalampakis G, Pikazis D. Autopathogenic correclation of peridontitis and rheumatoid arthritis. Rheumatology. 2011;50:1189-1193.
  17. De Smit M, Westra A, Vissink A, Doornbos-van der Meer B, van Winkelhoff AJ, Brouwer E. Patients with rheumatoid arthritis and periodontitis have higher disease activity and a more pronounced antibody response against Porphyromonas gingivalis. Ann Rheum Dis. 2012;71:A26-A27.
  18. van Venrooij WJ, Pruijn GJ. Citrullination: A small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000;2:249-251.
  19. Van Venrooij WJ, Pruijin GJ. An important step towards completing the rheumatoid arthritis cycle. Arthritis Res Ther. 2008;10:117.
  20. Willemze A, Ioan-Facsinay A, El-Gabalawy H. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis. J Rheum. 2008;35:2282-2284.
  21. Lundberg, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009-3019.
  22. Demoruelle MK, Deane K. Antibodies to citrullinated protein antigens (ACPAs): Clinical and pathophysiologic significance. Curr Rheum Rep. 2011;13:421-430.
  23. Willemze A, Trouw LA, Toes RE, Huizinga TWJ. The influence of ACPA status and characteristics on the course of RA. Nature Rev Rheum. 2012;8:144-152.
  24. Darrah E, Rosen A, Giles JT, Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: Novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis. 2012;71:92-98.
  25. Brink M, Ronnelid J, Hannson M, et al. Antibodies against native collagen and citrullinated proteins precede the development of rheumatoid arthritis with a consecutive pattern. Ann Rheum Dis. 2012; 71:A22.
  26. Ponchel F, Hensor EMA, Parmar R, et al. Predicting the evolution of inflammatory arthritis in ACPA-positive individuals: Can T cell subset help? Ann Rheum Dis. 2012;71:A21-A22.
  27. Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010; 6:727-730.
  28. De Pablo P, Dietrich T, Chapple I, et al. Is periodontal disease a risk factor for rheumatoid arthritis? The anticitrullinated antibody repertoire in periodontal disease. Ann Rheum Dis. 2012;71:28-29.
  29. Mikuls TR, Payne JB, Reinhardt RA, et al. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol. 2009;9:38-42.
  30. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol. 2010;37:1105-1112.
  31. Kinloch AJ, Alzabin S, Brintnell W, et al. Immunization with Porphyromonas gingivalis enolase induces autoimmunity to mammalian alpha-enolase and arthritis in DR4-IE-transgenic mice. Arthritis Rheum. 2011;12:3818-3823.
  32. Queiroz-Junior CM, Madeura FM, Coelho FM, et al. Experimental arthritis triggers periodontal disease in mice: Involvement of TNF-alpha and the oral microbiota. J Immunol. 2011;187:3821-3830.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:historicalPeriodontal diseaseResearchRheumatoid arthritisrheumatologist

Related Articles

    Periodontitis May Provide Insight into RA

    March 12, 2018

    Researchers explored the role of carbamylated protein (CarP) and neutrophil extracellular traps (NETs) in periodontitis and rheumatoid arthritis (RA). The results showed significantly higher levels of CarP and NETs in patients with both RA and periodontitis than in healthy controls. The data suggest that RA and periodontitis may share an underlying pathogenic mechanism…

    ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints

    February 1, 2013

    Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease

    A Meeting of the Minds for RA Research

    August 1, 2011

    REF investigators gather to share research progress and trade advice

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    Rheumatoid Arthritis Research Provides New Insights on Risk Factors, Identification Tools, Intervention

    October 11, 2016

    Established wisdom holds that patients with rheumatoid arthritis (RA) will fare better if their disease is diagnosed as early as possible, and treatments with disease-modifying drugs are started before inflammation can do more damage to joints and tissue. Usually, early diagnosis means spotting the clinical signs of disease, but new research tells us more about…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences